BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38815898)

  • 1. Potential applications of dual haptoglobin expression in the reclassification and treatment of hepatocellular carcinoma.
    Liu L; Hao S; Gou S; Tang X; Zhang Y; Cai D; Xiao M; Zhang X; Zhang D; Shen J; Li Y; Chen Y; Zhao Y; Deng S; Wu X; Li M; Zhang Z; Xiao Z; Du F
    Transl Res; 2024 May; 272():19-40. PubMed ID: 38815898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.
    Tai CS; Lin YR; Teng TH; Lin PY; Tu SJ; Chou CH; Huang YR; Huang WC; Weng SL; Huang HD; Chen YL; Chen WL
    PLoS One; 2017; 12(2):e0171269. PubMed ID: 28158312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
    Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1
    Liang Y; Zhong D; Yang Q; Tang Y; Qin Y; Su Y; Huang X; Shang J
    J Hepatocell Carcinoma; 2024; 11():373-383. PubMed ID: 38410699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release.
    Arredouani M; Matthijs P; Van Hoeyveld E; Kasran A; Baumann H; Ceuppens JL; Stevens E
    Immunology; 2003 Feb; 108(2):144-51. PubMed ID: 12562322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
    Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
    Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma.
    Cao L; Liu M; Ma X; Rong P; Zhang J; Wang W
    Curr Med Chem; 2024; 31(17):2414-2430. PubMed ID: 37936457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6
    Li X; Gao Z; Chen J; Feng S; Luo X; Shi Y; Tang Z; Liu W; Zhang X; Huang A; Gao Q; Ke A; Zhou J; Fan J; Fu X; Ding Z
    Front Oncol; 2023; 13():1099385. PubMed ID: 37593098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell Sequencing Identifies the Heterogeneity of CD8+ T Cells and Novel Biomarker Genes in Hepatocellular Carcinoma.
    Wang H; Fu Y; Da BB; Xiong G
    J Healthc Eng; 2022; 2022():8256314. PubMed ID: 35449866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overexpression of Nei endonuclease VIII-like protein 3 in hepatocellular carcinoma indicates increased levels of immune infiltration and an unfavorable prognosis].
    Wang GN; Zhang YP; Wang MC; Han W; Zhang YC
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):986-995. PubMed ID: 37872095
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S; Zhang L; Wang H
    Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of prognostic value and immune infiltration of IAPs family in hepatocellular carcinoma.
    Yang X; Yu X; Nie H; Jiang W; Zhou J; Ou C; He X
    J Cancer; 2023; 14(15):2848-2866. PubMed ID: 37781078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive analysis of the potential role of necroptosis in hepatocellular carcinoma using single-cell RNA Seq and bulk RNA Seq.
    Chen J; Chen C; Tao L; Cai Y; Wang C
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13841-13853. PubMed ID: 37535163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and validation of a novel lysosomal signature for hepatocellular carcinoma prognosis, diagnosis, and therapeutic decision-making.
    Chen J; Gao G; He Y; Zhang Y; Wu H; Dai P; Zheng Q; Huang H; Weng J; Zheng Y; Huang Y
    Sci Rep; 2023 Dec; 13(1):22624. PubMed ID: 38114725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis.
    Shirai K; Hikita H; Sakamori R; Doi A; Tahata Y; Sakane S; Kamada Y; Murai K; Nishio A; Yamada R; Kodama T; Nozaki Y; Kakita N; Ishida H; Nakanishi F; Morishita N; Imanaka K; Sakakibara M; Tatsumi T; Miyoshi E; Takehara T
    PLoS One; 2022; 17(12):e0279416. PubMed ID: 36542633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma.
    Bai J; Tang R; Zhou K; Chang J; Wang H; Zhang Q; Shi J; Sun C
    BMC Med Genomics; 2022 Oct; 15(1):222. PubMed ID: 36284275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and potential mechanism of cellular senescence and tumor microenvironment in hepatocellular carcinoma: Insights from bulk transcriptomics and single-cell sequencing analysis.
    Qu C; Wu Q; Lu J; Li F
    Environ Toxicol; 2024 May; 39(5):2512-2527. PubMed ID: 38189188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration.
    Wang H; Chen W; Qi Y; Liu D; Liu Z; Zhang Q; Yi Y; Wang J; Wu W
    Dig Dis Sci; 2023 May; 68(5):1923-1935. PubMed ID: 36583803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.